FairScope Lab
EN 繁中 简中

REGN

Valuation Healthcare · Biotechnology Data as of 2025-12-31

P/E Ratio · Metrics

P/E Ratio

24.56

PEG Ratio

0.56

Dividend Yield

-

Gross Margin

84.95%

Net Margin

21.74%

Revenue CAGR 3Y

4.39%

ROE

10.81%

ROA

8.33%

Buyback Yield

-0.28%

Current Ratio

4.13

Magic Earn Yield

5.12%

Altman Z-Score

7.17

Fair Value River

Score

Valuation 55
Profitability 46
Growth 15
Health 100
Yield 0
← Back to Dashboard